New Zealand markets closed

PhaseBio Pharmaceuticals, Inc. (PHAS)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.07010.0000 (0.00%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts2222
Avg. Estimate-0.35-0.27-1.19-1.06
Low estimate-0.39-0.34-1.3-1.73
High estimate-0.3-0.21-1.08-0.4
Year ago EPS-0.66-0.9-2.98-1.19
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts2212
Avg. EstimateN/A4.5M9.32M4.61M
Low estimateN/AN/A9.32MN/A
High estimateN/A9M9.32M9.22M
Year ago salesN/A158k10.83M9.32M
Sales growth (year/est)N/A2,748.10%-14.00%-50.50%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-0.61-0.59-0.66-0.31
Actual EPS-0.66-0.9-0.23-0.34
Difference-0.05-0.310.43-0.03
Surprise %-8.20%-52.50%65.20%-9.70%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-0.35-0.27-1.19-1.06
7 days ago-0.37-0.32-1.26-0.99
30 days ago-0.34-0.3-1.21-1.23
60 days ago-0.33-0.21-1.07-1.21
90 days ago-0.33-0.21-1.07-1.21
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesPHASIndustrySector(s)S&P 500
Current qtr.47.00%N/AN/AN/A
Next qtr.70.00%N/AN/AN/A
Current year60.10%N/AN/AN/A
Next year10.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A